(DERM) $1.20--MC $20m--11 x Marketed Drugs + another Drug in ongoing Phase 3 trial with data readout coming in Q2 ...Company trading at Cash balance of $35 million and annual revenue tops $70 million
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.